About HealthPartners Institute
Clinical Trials at HealthPartners Institute
During the past decade, HealthPartners Institute conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on
average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "HealthPartners Institute" #1 sponsor was "Seagen Inc." with 4 trials, followed by "Astellas Pharma Global Development, Inc." with 1 trials
sponsored, "Exact Sciences Corporation" with 1 trials sponsored, "Incyte Corporation" with 1 trials sponsored and "Pfizer"
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "HealthPartners Institute"
#1 collaborator was "Merck Sharp & Dohme LLC" with 4 trials as a collaborator and "Genmab" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at HealthPartners Institute
According to Clinical.Site data, the most researched conditions in "HealthPartners Institute" are
"Carcinoma, Non-Small-Cell Lung" (2 trials), "Colorectal Neoplasms" (2 trials), "HIV Infections" (2 trials), "Melanoma" (2 trials) and "Advanced Breast Cancer" (1 trials). Many other conditions were trialed in "HealthPartners Institute" in a lesser frequency.
Clinical Trials Intervention Types at HealthPartners Institute
Most popular intervention types in "HealthPartners Institute" are "Drug" (7 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "fluorouracil" (2 trials), "oxaliplatin" (2 trials), "pembrolizumab" (2 trials), "trastuzumab" (2 trials) and "tucatinib" (2 trials). Other intervention names were less common.
Clinical Trials Genders at HealthPartners Institute
The vast majority of trials in "HealthPartners Institute" are
10 trials for "All" genders.
Clinical Trials Status at HealthPartners Institute
Currently, there are NaN active trials in "HealthPartners Institute".
undefined are not yet recruiting,
4 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in HealthPartners Institute,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in HealthPartners Institute, 1 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".